Patents by Inventor Valeria Zucchelli

Valeria Zucchelli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120022056
    Abstract: Compounds of formula (I) wherein R1, R2, X, A, Y, B, Z1, Q, p, r and s are defined in the specification for treating inter alia psychotic disorders, depressive disorders, anxiety disorders and sexual dysfunctions.
    Type: Application
    Filed: August 29, 2005
    Publication date: January 26, 2012
    Inventors: Jonathan Bentley, Markus Bergauer, Babara Bertani, Matteo Biagetti, Manuela Borriello, Steven Mark Bromidge, Massimo Gianotti, Enrica Granci, Colin Philip Leslie, Alessandra Pasquarello, Valeria Zucchelli
  • Patent number: 7928108
    Abstract: The invention provides 3-(methyloxy)-1-{4-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]butyl}-2(1H)-pyridinone of formula (I), or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: April 3, 2008
    Date of Patent: April 19, 2011
    Assignee: Glaxo Group Limited
    Inventors: Gabriella Gentile, Valeria Zucchelli
  • Publication number: 20100075982
    Abstract: The invention provides 3-(methyloxy)-1-{4-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]butyl}-2(1H)-pyridinone of formula (I), or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: April 3, 2008
    Publication date: March 25, 2010
    Inventors: Gabriella Gentile, Valeria Zucchelli
  • Publication number: 20100004452
    Abstract: Disclosed are compounds of formula (I) wherein R1 is C1-6alkyl, halo or haloC1-6alkyl; R2 is hydrogen or C1-6alkyl; is a single or double bond; each R3 and R4, which may be the same or different, are hydrogen, C1-6alkyl or haloC1-6alkyl; wherein i) when is a double bond p and q are 1, and ii) when is a single bond, p and q are 2, and one of R3 and one of R4, together with their interconnecting atoms, forms a cyclopropane ring which may be substituted by one or two halo or methyl groups, which groups may be the same or different; X is CH or N; when present each R5, which may be the same or different, is C1-6alkyl or halo; or two R5 groups may join to form a bridge, which bridge contains one or two atoms; n is 0, 1, 2 or 3; when present each R6 which may be the same or different, is C1-6alkyl or halo; and m is 0, 1, 2 or 3.
    Type: Application
    Filed: September 24, 2007
    Publication date: January 7, 2010
    Inventors: Barbara Bertani, Steven Mark Bromidge, Massimo Gianotti, Alessandra Pasquarello, Valeria Zucchelli
  • Publication number: 20090076274
    Abstract: Intermediates useful in the preparation of compounds of formula (I) and pharmaceutically acceptable salts thereof are disclosed: wherein A, R1, R2, R3, , p, q, and X are as defined in the specification.
    Type: Application
    Filed: November 12, 2008
    Publication date: March 19, 2009
    Inventors: Barbara Bertani, Manuela Borriello, Andrea Bozzoli, Steven Mark Bromidge, Enrica Granci, Colin Leslie, Halina Serfinowska, Luigi Stasi, Antonio Vong, Valeria Zucchelli
  • Publication number: 20060264429
    Abstract: Compounds of formula (I) and pharmaceutically acceptable salts thereof are disclosed: wherein A, R1, R2, R3, p, q, A and X are as defined in the specification. Preparation of the compounds and uses in the treatment of CNS and other disorders, including depression and anxiety, are also disclosed.
    Type: Application
    Filed: November 20, 2003
    Publication date: November 23, 2006
    Inventors: Barbara Bertani, Manuela Borriello, Andrea Bozzoli, Steven Bromidge, Enrica Granci, Colin Leslie, Halina Serfinowska, Luigi Stasi, Antonio Vong, Valeria Zucchelli